HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyasu Kato Selected Research

Neoadjuvant Therapy

6/2023Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study.
12/2022DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer.
12/2020Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
9/2019Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
11/2017The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyasu Kato Research Topics

Disease

73Neoplasms (Cancer)
05/2024 - 02/2005
31Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 07/2009
21Ovarian Neoplasms (Ovarian Cancer)
07/2023 - 09/2010
20Carcinoma (Carcinomatosis)
03/2024 - 11/2003
15Endometrial Neoplasms (Endometrial Cancer)
05/2024 - 09/2010
7Adenocarcinoma
12/2023 - 12/2009
7Carcinosarcoma
10/2023 - 02/2012
5Neoplasm Metastasis (Metastasis)
08/2021 - 05/2017
4Breast Neoplasms (Breast Cancer)
03/2024 - 02/2012
4Ovarian Epithelial Carcinoma
03/2024 - 10/2020
4Leiomyosarcoma
05/2023 - 12/2019
4Endometriosis
02/2021 - 12/2008
3Myoma
02/2024 - 01/2023
3Hemorrhage
01/2024 - 10/2019
3Lymphatic Metastasis
10/2023 - 10/2019
3Residual Neoplasm
08/2023 - 02/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2021 - 10/2012
3Ascites
01/2021 - 01/2017
3Cicatrix (Scar)
09/2020 - 10/2019
2Carcinogenesis
10/2023 - 05/2019
2Disease Progression
01/2023 - 01/2018
2Infections
01/2023 - 03/2020
2Emergence Delirium
11/2022 - 01/2021
2Endometrioid Carcinoma
05/2022 - 03/2020
1Microsatellite Instability
05/2024
1Protein Deficiency
01/2023
1Delirium
11/2022
1Ulcer
02/2022
1Fistula
02/2022
1Thymoma (Thymic Carcinoma)
10/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2018
9MicroRNAs (MicroRNA)IBA
02/2024 - 10/2017
8PlatinumIBA
05/2024 - 01/2014
8DNA (Deoxyribonucleic Acid)IBA
10/2023 - 05/2019
6Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2017
6human ERBB2 proteinIBA
10/2023 - 05/2012
4AntigensIBA
07/2023 - 10/2012
4Phosphotransferases (Kinase)IBA
06/2023 - 01/2016
4ErbB Receptors (EGF Receptor)IBA
02/2023 - 05/2012
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2017
3RNA (Ribonucleic Acid)IBA
09/2023 - 01/2018
3Estrogen ReceptorsIBA
06/2023 - 10/2019
3Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 10/2016
2eribulinFDA Link
03/2024 - 01/2014
2Epithelial Cell Adhesion MoleculeIBA
03/2024 - 01/2019
2MesothelinIBA
10/2023 - 11/2022
2Tumor Biomarkers (Tumor Markers)IBA
07/2023 - 10/2012
2LigandsIBA
06/2023 - 12/2022
2Folate Receptor 1IBA
01/2023 - 11/2022
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2023 - 11/2022
2Exonucleases (3' 5' Exonuclease)IBA
01/2023 - 05/2022
2Yi-Gan SanIBA
11/2022 - 01/2021
2polysulfideIBA
08/2021 - 01/2021
2Hyaluronic Acid (Hyaluronan)IBA
03/2020 - 02/2019
2Indicators and Reagents (Reagents)IBA
01/2018 - 02/2005
2Carboplatin (JM8)FDA LinkGeneric
11/2017 - 10/2016
2Hormones (Hormone)IBA
05/2012 - 02/2012
1Immune Checkpoint InhibitorsIBA
05/2024
1Surface Antigens (Surface Antigen)IBA
05/2024
1Glycoproteins (Glycoprotein)IBA
05/2024
1pembrolizumabIBA
05/2024
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024
1Alanine Transaminase (SGPT)IBA
01/2024
1TransferasesIBA
01/2024
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2023
1Transcription Factors (Transcription Factor)IBA
10/2023
1ChemokinesIBA
10/2023
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2023
1MART-1 AntigenIBA
08/2023
1Progesterone Receptors (Progesterone Receptor)IBA
06/2023
1TropomyosinIBA
06/2023
1Phenobarbital (Luminal)FDA Link
06/2023
1Testosterone (Sustanon)FDA Link
05/2023
1Androgen Receptors (Androgen Receptor)IBA
05/2023
1Epidermal Growth Factor (EGF)IBA
02/2023
1tyrosine receptor (receptor, tyrosine)IBA
02/2023
1DNA Polymerase IIIBA
01/2023
1trastuzumab deruxtecanIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1Topoisomerase I InhibitorsIBA
01/2023
1NucleotidesIBA
01/2023
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2022
1HydrogelsIBA
07/2022
1AcidsIBA
05/2022
1Bevacizumab (Avastin)FDA Link
02/2022
1BI 2536IBA
01/2022
1prexasertibIBA
01/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021

Therapy/Procedure

30Therapeutics
05/2024 - 09/2010
21Hysterectomy
05/2024 - 11/2003
18Drug Therapy (Chemotherapy)
05/2024 - 09/2010
15Brachytherapy
01/2023 - 05/2016
11Radiotherapy
07/2022 - 09/2011
8Lymph Node Excision (Lymph Node Dissection)
05/2024 - 09/2010
5Adjuvant Chemotherapy
05/2024 - 09/2010
5Neoadjuvant Therapy
06/2023 - 11/2017
4Chemoradiotherapy
01/2023 - 09/2010
3Salpingo-oophorectomy
05/2023 - 07/2020
2Aftercare (After-Treatment)
07/2023 - 09/2020
1Re-Irradiation
02/2022